European stocks and US futures rose early on Thursday as investors anticipated encouraging job data and held on to hopes of a vaccine. Pan-European Stoxx 600 SXXP, + 1.09% It increased 1.3%, following strong gains in Asian markets overnight. The German DAX DAX, + 1.76% The French CAC PX1 rose …
Read More »
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases for three decades and one of the leading experts on pandemics in the United States for the past four decades, spoke a few harsh words to public and federal authorities in the United States. Fauci said that SARS-CoV-2, …
Read More »
Text size Dirk Waem / Getty Images NASH was once the next big thing for big drug companies; a newly defined disorder that requires chronic treatment that affects millions of people in developed countries. Dozens of companies are developing drugs for the disease, which can cause life-threatening conditions like decompensated …
Read More »
Gilead Sciences Inc.’s COVID-19 drug remdesivir will cost much less than Wall Street analysts had predicted in a move that likely points to a more measured and responsible approach to the price of treatments and vaccines during the pandemic. Gilead GILD Shares, It gained 0.9% in trading on Monday following …
Read More »
Shares of Inovio Pharmaceuticals Inc. rebounded to a 20-year high in high volumes on Friday, erasing a previous sharp loss, after a longtime bull downgraded the Pennsylvania-based biotech company, and later that the company disclosed some terms of the funding agreement with the US Department of Defense announced earlier this …
Read More »